65 related articles for article (PubMed ID: 24966918)
1. The expression of S100P increases and promotes cellular proliferation by increasing nuclear translocation of β-catenin in endometrial cancer.
Guo L; Chen S; Jiang H; Huang J; Jin W; Yao S
Int J Clin Exp Pathol; 2014; 7(5):2102-12. PubMed ID: 24966918
[TBL] [Abstract][Full Text] [Related]
2. Beta-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
Am J Pathol; 2004 May; 164(5):1739-49. PubMed ID: 15111320
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation and nuclear localization of beta-catenin in endometrial carcinoma in response to progesterone therapy.
Saegusa M; Hamano M; Kuwata T; Yoshida T; Hashimura M; Akino F; Watanabe J; Kuramoto H; Okayasu I
Cancer Sci; 2003 Jan; 94(1):103-11. PubMed ID: 12708483
[TBL] [Abstract][Full Text] [Related]
4. Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9/GSK3β/β-catenin signaling.
Lin Y; Chen X; Lin L; Xu B; Zhu X; Lin X
Cell Mol Biol Lett; 2024 May; 29(1):63. PubMed ID: 38698330
[TBL] [Abstract][Full Text] [Related]
5. Eukaryotic initiation factor 3B downregulation suppresses cell proliferation, migration and invasion while it induces cell apoptosis by blocking the β-catenin pathway in endometrial cancer.
Min J; Chen H
Int J Clin Exp Pathol; 2019; 12(9):3595-3603. PubMed ID: 31934209
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial Calcium Uniporter (MCU) that Modulates Mitochondrial Calcium Uptake and Facilitates Endometrial Cancer Progression through Interaction with VDAC1.
Xiao H; Ma L; Ding J; Wang H; Bi X; Tan F; Piao W
Curr Cancer Drug Targets; 2024; 24(3):354-367. PubMed ID: 37702230
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Expression of Homeobox A5 in Endometrial Cancer on the mRNA and Protein Level.
Dziobek K; Oplawski M; Zmarzły N; Gabarek BO; Kiełbasiński R; Kiełbasiński K; Kieszkowski P; Talkowski K; Boroń D
Curr Pharm Biotechnol; 2020; 21(7):635-641. PubMed ID: 31880256
[TBL] [Abstract][Full Text] [Related]
8. Impact of heterogeneous nuclear ribonucleoprotein A/B subtype overexpression on the expression of cancer stem cell markers CD133 and CD44 and cellular proliferation capacity.
Wang M; Wang X; Cui Y; Wen X
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):101-108. PubMed ID: 38279469
[TBL] [Abstract][Full Text] [Related]
9. Proteogenomic insights suggest druggable pathways in endometrial carcinoma.
Dou Y; Katsnelson L; Gritsenko MA; Hu Y; Reva B; Hong R; Wang YT; Kolodziejczak I; Lu RJ; Tsai CF; Bu W; Liu W; Guo X; An E; Arend RC; Bavarva J; Chen L; Chu RK; Czekański A; Davoli T; Demicco EG; DeLair D; Devereaux K; Dhanasekaran SM; Dottino P; Dover B; Fillmore TL; Foxall M; Hermann CE; Hiltke T; Hostetter G; Jędryka M; Jewell SD; Johnson I; Kahn AG; Ku AT; Kumar-Sinha C; Kurzawa P; Lazar AJ; Lazcano R; Lei JT; Li Y; Liao Y; Lih TM; Lin TT; Martignetti JA; Masand RP; Matkowski R; McKerrow W; Mesri M; Monroe ME; Moon J; Moore RJ; Nestor MD; Newton C; Omelchenko T; Omenn GS; Payne SH; Petyuk VA; Robles AI; Rodriguez H; Ruggles KV; Rykunov D; Savage SR; Schepmoes AA; Shi T; Shi Z; Tan J; Taylor M; Thiagarajan M; Wang JM; Weitz KK; Wen B; Williams CM; Wu Y; Wyczalkowski MA; Yi X; Zhang X; Zhao R; Mutch D; Chinnaiyan AM; Smith RD; Nesvizhskii AI; Wang P; Wiznerowicz M; Ding L; Mani DR; Zhang H; Anderson ML; Rodland KD; Zhang B; Liu T; Fenyö D;
Cancer Cell; 2023 Sep; 41(9):1586-1605.e15. PubMed ID: 37567170
[TBL] [Abstract][Full Text] [Related]
10. Circulatory shear flow alters the viability and proliferation of circulating colon cancer cells.
Fan R; Emery T; Zhang Y; Xia Y; Sun J; Wan J
Sci Rep; 2016 Jun; 6():27073. PubMed ID: 27255403
[TBL] [Abstract][Full Text] [Related]
11. Nuclear Expression of β-Catenin Is Associated with Improved Outcomes in Endometrial Cancer.
Masciullo V; Susini T; Corrado G; Stepanova M; Baroni A; Renda I; Castiglione F; Minimo C; Bellacosa A; Chiofalo B; Vizza E; Scambia G
Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292090
[TBL] [Abstract][Full Text] [Related]
12. SIX3 function in cancer: progression and comprehensive analysis.
Ma TL; Zhu P; Chen JX; Hu YH; Xie J
Cancer Gene Ther; 2022 Nov; 29(11):1542-1549. PubMed ID: 35764712
[TBL] [Abstract][Full Text] [Related]
13. Calcium-binding protein S100P is a new target gene of MACC1, drives colorectal cancer metastasis and serves as a prognostic biomarker.
Schmid F; Dahlmann M; Röhrich H; Kobelt D; Hoffmann J; Burock S; Walther W; Stein U
Br J Cancer; 2022 Sep; 127(4):675-685. PubMed ID: 35597866
[TBL] [Abstract][Full Text] [Related]
14. Optimisation and validation of immunohistochemistry protocols for cancer research.
Ella-Tongwiis P; Makanga A; Shergill I; Fôn Hughes S
Histol Histopathol; 2021 Apr; 36(4):415-424. PubMed ID: 33616195
[TBL] [Abstract][Full Text] [Related]
15. TRIM27 acts as an oncogene and regulates cell proliferation and metastasis in non-small cell lung cancer through SIX3-β-catenin signaling.
Liu S; Tian Y; Zheng Y; Cheng Y; Zhang D; Jiang J; Li S
Aging (Albany NY); 2020 Dec; 12(24):25564-25580. PubMed ID: 33264103
[TBL] [Abstract][Full Text] [Related]
16. The role of antibody expression and their association with bladder cancer recurrence: a single-centre prospective clinical-pilot study in 35 patients.
Ella-Tongwiis P; Lamb RM; Makanga A; Shergill I; Hughes SF
BMC Urol; 2020 Nov; 20(1):187. PubMed ID: 33238953
[TBL] [Abstract][Full Text] [Related]
17. Calcium-Binding Protein S100P Promotes Tumor Progression but Enhances Chemosensitivity in Breast Cancer.
Cong Y; Cui Y; Wang S; Jiang L; Cao J; Zhu S; Birkin E; Lane J; Ruge F; Jiang WG; Qiao G
Front Oncol; 2020; 10():566302. PubMed ID: 33042844
[TBL] [Abstract][Full Text] [Related]
18. Promotion of the occurrence of endometrioid carcinoma by S100 calcium binding protein P.
Zhang D; Chen X; Xia H; Wang L; Zhao H; Xu B; Zhang A; Zhang W
BMC Cancer; 2020 Sep; 20(1):845. PubMed ID: 32883230
[TBL] [Abstract][Full Text] [Related]
19. S100P and Ezrin promote trans-endothelial migration of triple negative breast cancer cells.
Kikuchi K; McNamara KM; Miki Y; Iwabuchi E; Kanai A; Miyashita M; Ishida T; Sasano H
Cell Oncol (Dordr); 2019 Feb; 42(1):67-80. PubMed ID: 30244410
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
